Kayawell
  • Switglim MV 2/0.3 Tablet

Switglim MV 2/0.3 Tablet

Picture of Switglim MV 2/0.3 Tablet
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg) Primary uses of : Type 2 diabetes
Manufacturer: Akumentis Healthcare Ltd
*
₹ 92.00 incl tax
Composition Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Potentially Unsafe With Alcohol
Side Effect Common Hypoglycemia (low blood sugar level), Nausea, Diarrhoea, Altered taste, Flatulence, Stomach pain, Headache, Skin rash, Respiratory tract infection.
How to works How Switglim MV Tablet ER works Switglim MV 2/0.3 Tablet is a combination of three antidiabetic medicines: Glimepiride, metformin and voglibose. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas to lower the blood glucose. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body's sensitivity to insulin. Voglibose is an alpha-glucosidase inhibitor which prevents breakdown of complex sugars into simple sugars such as glucose. This prevents blood glucose from rising very high after meals.

We help patients connect with local pharmacy stores to fulfill their extensive medical needs. Thus, through our extensive portal and services we ensure you get access to the best and most genuine health products at reasonable price, with the highest savings in the shortest time possible.

KayaWell Icon

Information

Customer service

Powered by Kayawell
Copyright © 2024 Kayawell. All rights reserved.